Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers

Huixiang Liu,Hongchang Zhou,Tianyu Cai,Aijuan Yang,Meitong Zang,Jie Xing
DOI: https://doi.org/10.1128/aac.00260-18
IF: 5.938
2018-01-01
Antimicrobial Agents and Chemotherapy
Abstract:As a partner antimalarial for artemisinin drug-based combination therapy (ACT), piperaquine (PQ) can be metabolized into two major metabolites, including piperaquine N -oxide (M1) and piperaquine N , N -dioxide (M2). To better understand the antimalarial potency of PQ, the antimalarial activity of the PQ metabolites (M1 and M2) was studied in vitro (in Plasmodium falciparum strains Pf 3D7 and Pf Dd2) and in vivo (in the murine species Plasmodium yoelii ) in this study.
What problem does this paper attempt to address?